Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00058461
Status:
TERMINATED
Last Update Posted:
2013-10-08
First Post:
2003-04-07
Brief Title:
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkins Lymphoma or Acute Lymphoblastic Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Childhood Small Noncleaved Cell Lymphoma |
| B-cell Childhood Acute Lymphoblastic Leukemia |
| Childhood Burkitt Lymphoma |
| Childhood Diffuse Large Cell Lymphoma |
| Childhood Immunoblastic Large Cell Lymphoma |
| L3 Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Large Cell Lymphoma |
| Recurrent Childhood Lymphoblastic Lymphoma |
Keywords: